Publicaciones en colaboración con investigadoras/es de Universidad de Cantabria (15)

2022

  1. Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy

    Clinical and experimental rheumatology, Vol. 40, Núm. 5, pp. 988-992

2021

  1. HLA association with the susceptibility to anti-synthetase syndrome

    Joint Bone Spine, Vol. 88, Núm. 3

  2. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 38, Núm. 6, pp. 1201-1205

  2. Bacteremia in systemic lupus erythematosus in patients from a Spanish registry: Risk factors, clinical and microbiological characteristics, and outcomes

    Journal of Rheumatology, Vol. 47, Núm. 2, pp. 234-240

  3. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis

    Clinical and experimental rheumatology, Vol. 37, Núm. 3, pp. 465-473

2017

  1. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA

    Rheumatology International, Vol. 37, Núm. 4, pp. 479-485

2012

  1. Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: Results of an open-label, phase 3b study

    Journal of Pain Research, Vol. 5, pp. 121-138

  2. Toll-like receptor 9 gene polymorphisms in polymyalgia rheumatica and giant cell arteritis

    Scandinavian Journal of Rheumatology

  3. Utilizing registries in systemic lupus erythematosus clinical research

    Expert Review of Clinical Immunology, Vol. 8, Núm. 4, pp. 353-360

2010

  1. Utilización de terapias hiperestrogénicas en el lupus eritematoso sistémico

    Reumatologia Clinica

2009

  1. Elderly onset rheumatoid arthritis: Differential diagnosis and choice of first-line and subsequent therapy

    Drugs and Aging, Vol. 26, Núm. 9, pp. 739-750

2005

  1. Outcome of late-onset rheumatoid arthritis

    Clinical Rheumatology, Vol. 24, Núm. 5, pp. 485-489

2003

  1. Clinical, immunogenetic and outcome features of hispanic systemic lupus erythematosus patients of different ethnic ancestry

    Lupus, Vol. 12, Núm. 5, pp. 377-385